Liquid biopsy, genetic testing offer new potent weapons for
diagnosis and treatment
CORE conducts unique Startup Pitch Fest to select and reward
innovative and potentially path-breaking entrepreneurial ideas in the
healthcare domain
India’s most trusted diagnostics partner CORE Diagnostics Pvt.
Ltd is supporting a comprehensive discussion platform for Oncologists and
medical experts to talk in depth about the Indian perspectives on genetic
mutation and its role in augmenting cancer risk at the 2nd chapter
of the Indian Cancer Congress. Over 3500 oncologists have converged at
the conference to talk about latest strategies in treatment and prevention
against cancer.
The event is being held from Nov 8-12 here at the Silicon
Valley of India and has experts in medical oncology deliberating upon the
Indian as well as global perspectives in the incidence of different types of
cancers and the causes of their rising prevalence. A rapidly expanding
start up and an expert in Oncology testing, CORE have constantly differentiated
themselves by their innovative edge in the diagnostics market.
Keeping up with the newest technologies in the cancer detection
and prevention space, CORE has an entire section dedicated to the latest buzz
in the segment called COREtalks at their booth. Some of
the featured talks include “BRCA: An Indian perspective on incidence and
patterns,” " Liquid Biopsy: An answer to when tissue is an issue,"
and Next Generation Sequencing and beyond in the management of Cancers - Where
do we stand?” CORE is also hosting a Lunch Symposium on Machine Learning
& Artificial Intelligence in Oncology - The Myth & the Reality as well
as participating on several debates and panel discussions.
CORE Diagnostics has also initiated a one of its kind effort to
boost innovation as a means to usher in potentially game changing ideas in the
field of Indian healthcare/
Underlining the need for promoting innovation in healthcare,
CORE Diagnostics’ Founder & Managing Director, Zoya Brar said, “Putting
appropriate thrust on innovation can bring about revolutionary solutions in
healthcare. This is particularly important for a country like India where
dynamic ideas are needed to expand the reach of quality healthcare to rural as
well as remote areas. In this direction, for the first time ever at a
conference, with a platform as great as the ICC, we’re hosting a unique
‘Startup Pitch Fest’. This fest will provide a one of its kind platform to
boost brilliant ideas in the healthcare domain that can play a pivotal role in
diagnosis and positively impact patient treatment. The winner gets cash prizes
worth Rs 3 lakhs. I’m very excited and look forward to hearing from the
selected finalists for COREcatalyst on November 10.”
No comments:
Post a Comment